RMSYF (Ramsay Health Care) Research & Development: $0 Mil (TTM As of Dec. 2025)


RMSYF Ramsay Health Care Ltd RMSYF
82 GF Score
Price $27.46
GF Value $32.23
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Ramsay Health Care Research & Development?

Ramsay Health Care RMSYF 82 Research & Development is $0 Mil as of Dec. 2025. GuruFocus rates RMSYF with a GF Score™ of 82/100 and a GF Value™ of $32.23 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Ramsay Health Care's Research & Development for the six months ended in Dec. 2025 was $0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was $0 Mil.

Ramsay Health Care  (OTCPK:RMSYF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Ramsay Health Care Research & Development Related Terms

Ramsay Health Care Research & Development Historical Data

* Premium members only.

The historical data trend for Ramsay Health Care's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ramsay Health Care Research & Development Chart

Ramsay Health Care Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Ramsay Health Care Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
RMSYF
82GF Score
Ramsay Health Care Ltd RMSYF
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ramsay Health Care Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0 Mil mean?
Ramsay Health Care (RMSYF) has a Research & Development of $0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Ramsay Health Care and its competitors.
Is Ramsay Health Care's Research & Development too high?
Ramsay Health Care's current Research & Development is $0 Mil. Overall, Ramsay Health Care has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ramsay Health Care's Research & Development compare to HCA and THC?
Ramsay Health Care's Research & Development of $0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Ramsay Health Care and its competitors. Ramsay Health Care's current Research & Development is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ramsay Health Care stock overvalued right now?
Based on GuruFocus' analysis, Ramsay Health Care (RMSYF) is currently considered Modestly Undervalued. The stock's GF Value™ is $32.23, compared to a current price of $27.46 — trading 14.8% below its estimated fair value. The current Research & Development is $0 Mil. Ramsay Health Care's overall GF Score™ is 82/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Ramsay Health Care (RMSYF), the current Research & Development is $0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ramsay Health Care (RMSYF) Overvalued in 2026?

Based on GuruFocus' analysis, Ramsay Health Care stock appears to be undervalued. The current stock price of $27.46 is trading 14.8% below its estimated GF Value™ of $32.23. GuruFocus considers Ramsay Health Care to be Modestly Undervalued.

Key valuation signals for RMSYF:

  • Research & Development: $0 Mil
  • GF Value™: $32.23 vs. price of $27.46 (14.8% below fair value)
  • GF Score™: 82/100 with 4 warning signs

No single metric tells the full story. See the RMSYF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ramsay Health Care Business Description

Address 126 Phillip Street, Suite 18.03, Level 18, Deutsche Bank Place, Sydney, NSW, AUS, 2000
Ramsay Health Care is one of the largest private healthcare providers in the world, with more than 500 sites across about eight countries. The key markets in which it operates are Australia, France, the UK, and Sweden. It is the largest private hospital group in each of these markets except for the UK, where it is the largest independent supplier to the NHS. Ramsay Santé, which operates the European regions other than the UK, is a 53%-owned subsidiary of Ramsay Health Care. The company typically earns about two-thirds of consolidated earnings in Australia. Ramsay Health Care undertakes both private and publicly funded healthcare.
82GF Score

Get the complete analysis for RMSYF

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$27.46
Price
$32.23
GF Value